Diabetes

Filter

Stem Cell Therapy Zimislecel Shows Promise in Type 1 Diabetes

June 2025

Discover how zimislecel enables insulin independence in patients with Type 1 diabetes, showing strong efficacy in early clinical data.

Type 2 Diabetes Triples COVID-19 Death Risk, Study Finds

Research confirms Type 2 diabetes greatly increases risks of death, severity, and ventilation need in COVID-19 cases.

One in Three Diabetic Patients May Develop Delirium

Diabetes significantly raises the risk of delirium, but metformin and intranasal insulin may offer protective effects.

Adult-Onset Type 1 Diabetes Tied to Higher Mortality and Cardiovascular Risk

Discover how adult-onset type 1 diabetes is linked to higher death rates and cardiovascular events, especially post-40 diagnosis.

New Diabetes Risk Model Recommends Personalised Prevention Strategies

New model predicts diabetes risk and recommends personalised prevention, including lifestyle changes or metformin, for diverse populations.

Do GLP-1 Receptor Agonists Reduce Alcohol Intake in Patients With Obesity?

Learn how GLP-1 receptor agonists show promise in reducing alcohol consumption and aiding weight loss in obesity treatment.

Mental Health Decline Observed in Metabolic Disease Patients Post-Pandemic

A recent study utilizing UK Biobank data has identified a significant rise in new-onset mental health disorders—specifically depression, anxiety, and alcohol use disorders—among adults with metabolic diseases such as hypertension, diabetes, and obesity in the aftermath of the COVID-19 pandemic.

Is AI Safe and Effective in T2D Insulin Titration?

AI safely matches senior doctors in hospital insulin dosing for T2D, easing clinical load without compromising care.

Semaglutide Shows Promise in Treating MASH and Liver Fibrosis

Semaglutide significantly improves liver inflammation and fibrosis in MASH patients, offering new hope for clinical management.

Loading posts...

« Previous 1 2 3 4 … 34 Next »